4.7 Article

Clinical Utility of Circulating Tumor Cells for Predicting Major Histopathological Response after Neoadjuvant Chemoradiotherapy in Patients with Esophageal Cancer

Related references

Note: Only part of the references are listed.
Article Surgery

Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer A Multicenter Propensity Matched Study

Berend J. van der Wilk et al.

Summary: In this retrospective study, the overall survival and progression-free survival of esophageal cancer patients with clinically complete response undergoing active surveillance or immediate surgery were not significantly different. Active surveillance with postponed surgery for recurrent disease did not result in a higher rate of distant dissemination or more severe adverse postoperative outcomes.

ANNALS OF SURGERY (2021)

Review Oncology

Liquid biopsy for esophageal cancer: Is detection of circulating cell-free DNA as a biomarker feasible?

Zuyang Yuan et al.

Summary: Esophageal cancer is a common global health issue with late diagnosis and lack of effective therapy. Liquid biopsies, specifically cfDNA, show promise in non-invasive cancer diagnosis and patient monitoring. However, research on the use of cfDNA in esophageal cancer is limited.

CANCER COMMUNICATIONS (2021)

Article Oncology

Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker

Byeong Geun Song et al.

Summary: CTCs can be reliably identified in early stages of PDACs, with CTC count potentially serving as a prognostic marker for resectable PDAC patients' survival.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Enhancing Prediction Performance by Add-On Combining Circulating Tumor Cell Count, CD45neg EpCAMneg Cell Count on Colorectal Cancer, Advance, and Metastasis

Sherry Yueh-Hsia Chiu et al.

Summary: The combination of negative selection CTC enumeration with conventional biomarkers improves predictive performance for colorectal cancer, particularly for advanced and metastatic cases.

CANCERS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Accuracy of 18F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer

Maria J. Valkema et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Article Gastroenterology & Hepatology

Prognostic value of circulating tumor cells in esophageal cancer

Hai-Tao Xu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Article Medical Laboratory Technology

Circulating Epithelial Cells in Patients with Benign Colon Diseases

Klaus Pantel et al.

CLINICAL CHEMISTRY (2012)